In addition to this, patients with high MT1G expression also exhibited poor prognostic outcomes in ACC, KICH, and KIRP, which may be related to the unique pathogenesis of KIRP, which is independent of disease progression and clinical outcomes in addition to KIRC, despite its exact origin (34). This evidence concerns the gene MT1G and adrenal cortex carcinoma.